BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Oct 15, 2019; 11(10): 768-772
Published online Oct 15, 2019. doi: 10.4251/wjgo.v11.i10.768
Cancer-specific metabolism: Promising approaches for colorectal cancer treatment
Keun-Yeong Jeong
Keun-Yeong Jeong, The Research Center, Metimedi Pharmaceuticals, Incheon 22006, South Korea
Author contributions: Jeong KY conceived the study and drafted the manuscript; This author approved the final version of the article.
Conflict-of-interest statement: This author has no conflicts of interest to declare.
Corresponding author: Keun-Yeong Jeong, PhD, Executive Vice President, The Research Center, Metimedi Pharmaceuticals, 263, Central-ro, Yeonsu-Gu, Incheon 22006, South Korea. alvirus@naver.com
Telephone: +82-32-2050541 Fax: +82-32-2050542
Received: July 17, 2019
Peer-review started: July 17, 2019
First decision: August 23, 2019
Revised: September 4, 2019
Accepted: September 10, 2019
Article in press: September 10, 2019
Published online: October 15, 2019
Processing time: 105 Days and 6.1 Hours
Core Tip

Core tip: Studies of cancer-specific metabolism have been conducted for over half a century, and the importance of promoting aerobic glycolysis, cancer favorable metabolic changes in mitochondria, and abnormal expression of drug-metabolizing enzymes has been emphasized through the established theories to date. Cancer-specific metabolism is a major theoretical background that can explain the process of survival and proliferation of most solid cancers. Developing cancer-specific metabolism-target drugs provide a novel treatable method that will be critical in this new area of treatment strategies for colorectal cancer. They have not yet been conquered and have infinite growth potential.

Write to the Help Desk